Fact sheet: Carnegie Medical

Fund information

Fund name
Carnegie Medical 1A EUR
Fund company manager
Carnegie Asset Management
Fund type
SIB
Fund manager
Angelica Fatouros
since 01/07/2008
Fund objective
The investment objective of the C WorldWide Medical fund is to achieve long-term capital growth by investing globally in a limited number of companies within the healthcare sector. Most of the investments are in the major pharmaceutical companies, but also in smaller and medium-sized companies.
Benchmark
MSCI World Healthcare
Investment style
Growth
Investment method
Shares

Performance snapshot

Quick stats

1 Year return

-3.03 %

1 Year rank in sector

28/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 513.8 m

FE Risk score

152

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • North America
    76.9%
  • Continental Europe
    20.3%
  • UK
    2.8%
  • Pharmaceuticals
    42.5%
  • Biotechnology/Medical
    39.6%
  • Services
    17.9%
  • North American Equities
    76.9%
  • European Equities
    20.3%
  • UK Equities
    2.8%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund-5.43 %-6.24 %-3.03 %17.53 %71.57 %
Sector-2.14 %3.95 %6.57 %24.27 %99.62 %
Rank within sector30 / 3028 / 2928 / 2915 / 2618 / 23
Quartile th4 th4 th4 th3 rd4 th

Calendar performance

YTD-20172016201520142013
Fund1.63 %-14.37 %10.68 %38.82 %31.94 %
Sector12.56 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector26 / 2920 / 299 / 274 / 2416 / 23
Quartile th4 th3 rd2 nd1 st3 rd

Risk statistics

Alpha-2.06
Beta1.14
Sharpe0.18
Volatility18.93
Tracking error7.2
Information ratio-0.19
R-Squared0.86

Price movement

52 week high101.85
52 week low82.43
Current bid price0
Current offer price0
Current mid price91.86

Holdings by region

  • 76.9% North America
  • 20.3% Continental Europe
  • 2.8% UK

Holdings by sector

  • 42.5% Pharmaceuticals
  • 39.6% Biotechnology/Medical
  • 17.9% Services

Holdings by asset type

  • 76.9% North American Equities
  • 20.3% European Equities
  • 2.8% UK Equities

Individual holdings

  • 6.9% JOHNSON & JOHNSON
  • 6.4% UNITEDHEALTH GROUP INC
  • 5% GILEAD SCIENCES INC
  • 4.5% C WORLDWIDE MEDICAL SMALL & MID CAP
  • 4.2% ACTAVIS INC
  • 4% CELGENE CORP
  • 3.7% ROCHE HLDG AG
  • 3.4% AMGEN INC
  • 3% BIOGEN INC
  • 3% PFIZER INC